Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | X022411 | OT |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y014868 | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | OT |
no adverse event; HCP calling to report that patient received improperly stored VARIVAX and MMR II on 5/14/2025. No adverse effects reported. Caller was not able to provide time and temp details at time of call so precautionary AE filed. No additional AE. No PQC.; This spontaneous report was received from Nurse and refers to a specific patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-May-2025, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), lot #Y014868, expiration date: 03-Sep-2026, (strength, dose, dose number, route, anatomical location and vaccination scheme were not reported), as prophylaxis. On the same date, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #X022411, expiration date: 05-Jun-2025, (strength, dose, dose number, route, anatomical location and vaccination scheme were not reported), as prophylaxis. It was not reported temperature excursion details. No adverse events was reported.